Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells

被引:7
作者
Toyoda, Hidenao [1 ]
Nagai, Yuko [1 ]
Kojima, Aya [1 ]
Kinoshita-Toyoda, Akiko [1 ]
机构
[1] Ritsumeikan Univ, Fac Pharmaceut Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan
关键词
Podocalyxin; Embryonic stem cells; Keratan sulfate; Glycosaminoglycans; Induced pluripotent stem cells; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; GLYCOSAMINOGLYCAN-DERIVED OLIGOSACCHARIDES; HEPARAN-SULFATE; CHONDROITIN/DERMATAN SULFATES; MONOCLONAL-ANTIBODIES; STRUCTURAL-ANALYSIS; PROSTATE-CANCER; CARCINOMA-CELLS; IN-VITRO;
D O I
10.1007/s10719-016-9757-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Podocalyxin (PC) was first identified as a heavily sialylated transmembrane protein of glomerular podocytes. Recent studies suggest that PC is a remarkable glycoconjugate that acts as a universal glyco-carrier. The glycoforms of PC are responsible for multiple functions in normal tissue, human cancer cells, human embryonic stem cells (hESCs), and human induced pluripotent stem cells (hiPSCs). PC is employed as a major pluripotent marker of hESCs and hiPSCs. Among the general antibodies for human PC, TRA-1-60 and TRA-1-81 recognize the keratan sulfate (KS)-related structures. Therefore, It is worthwhile to summarize the outstanding chemical characteristic of PC, including the KS-related structures. Here, we review the glycoforms of PC and discuss the potential of PC as a novel KS proteoglycan in undifferentiated hESCs and hiPSCs.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [41] Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS)
    Anstee, D. J.
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2010, 17 (03) : 104 - 109
  • [42] Characterization of novel antibodies that recognize sialylated keratan sulfate and lacto-N-fucopentaose I on human induced pluripotent cells: comparison with existing antibodies
    Nakao, Hiromi
    Yamaguchi, Tomoko
    Kawabata, Kenji
    Higashi, Katsuaki
    Nonaka, Motohiro
    Tuiji, Makoto
    Nagai, Yuko
    Toyoda, Hidenao
    Yamaguchi, Yoshiki
    Kawasaki, Nobuko
    Kawasaki, Toshisuke
    [J]. GLYCOBIOLOGY, 2023, 33 (02) : 150 - 164
  • [43] In vitro models of pancreatic differentiation using embryonic stem or induced pluripotent stem cells
    Higuchi, Yuichiro
    Shiraki, Nobuaki
    Kume, Shoen
    [J]. CONGENITAL ANOMALIES, 2011, 51 (01) : 21 - 25
  • [44] Electrophysiological properties of pluripotent human and mouse embryonic stem cells
    Wang, K
    Xue, T
    Tsang, SY
    Van Huizen, R
    Wong, CW
    Lai, KW
    Ye, ZH
    Cheng, LZ
    Au, KW
    Zhang, J
    Li, GR
    Lau, CP
    Tse, HF
    Li, RA
    [J]. STEM CELLS, 2005, 23 (10) : 1526 - 1534
  • [45] Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells (hESCs) and and Induced Pluripotent Stem Cells (iPSCs)
    Bock, Allison M.
    Knorr, David
    Kaufman, Dan S.
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (74): : e50337
  • [46] Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure
    Gherghiceanu, Mihaela
    Barad, Lili
    Novak, Atara
    Reiter, Irina
    Itskovitz-Eldor, Joseph
    Binah, Ofer
    Popescu, L. M.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (11) : 2539 - 2551
  • [47] Effect of Different Feeding Schedules on The Survival and Neural Differentiation of Human Embryonic and Induced Pluripotent Stem Cells
    Jensen, Matthew B.
    Jager, Lindsey D.
    Cohen, Laura K.
    Kwok, Susanna S.
    Kwon, Jin M.
    Hall, Crystal A.
    [J]. JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2014, 31 (02): : 226 - 231
  • [48] BMP10 as a potent inducer of trophoblast differentiation in human embryonic and induced pluripotent stem cells
    Lichtner, Bjoern
    Knaus, Petra
    Lehrach, Hans
    Adjaye, James
    [J]. BIOMATERIALS, 2013, 34 (38) : 9789 - 9802
  • [49] Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells
    Irion, Stefan
    Clarke, Raedun L.
    Luche, Herve
    Kim, Injune
    Morrison, Sean J.
    Fehling, Hans-Joerg
    Keller, Gordon M.
    [J]. DEVELOPMENT, 2010, 137 (17): : 2829 - 2839
  • [50] Challenges of Stem Cell Therapy for Spinal Cord Injury: Human Embryonic Stem Cells, Endogenous Neural Stem Cells, or Induced Pluripotent Stem Cells?
    Ronaghi, Mohammad
    Erceg, Slaven
    Moreno-Manzano, Victoria
    Stojkovic, Miodrag
    [J]. STEM CELLS, 2010, 28 (01) : 93 - 99